ArticleACS medicinal chemistry letters2026
Targeted Protein Degradation and Metabolic Inhibition as Complementary Therapeutic Strategies: TEAD PROTACs and NAT8L Inhibitors in Oncology.
Anna C Renner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.